Abstract
Dyslipidemia is defined as abnormally levels of lipids in the blood. Different types of lipids and lipoproteins have been identified. Dyslipidemia is a single strong risk factor for the development of cardiovascular events and atherosclerosis is the most common. It has been described as a disease of the economically advanced societies, but recently, it has found its way into the semi-urban societies and among its dwellers, who are at the increasing risk of developing cardiovascular accidents. Hence, early identification and diagnosis of dyslipidemia at its earliest stage among this populace is a worthwhile cardiovascular preventive measure. The study of hyperlipidaemia is of considerable importance, mainly because of the involvement of lipids in cardiovascular diseases. The classification system of hyperlipidaemia is based on which plasma lipoprotein concentrations were increased. Fredrickson classification helped to put lipidology on the clinical map, though it was not a diagnostic classification. It gives little clue as to the aetiology of the disorder. Currently, a more descriptive classification is used for the primary hyperlipidaemia although they can be genetic or secondary factors. This review presents the overview of plasma lipids. This article illustrates the theoretical background and details about dyslipidemias. Keywords: Dyslipidemia, Atherogenic index, Hyperlipidaemia, Atherosclerosis, Lipoproteins
Cite
CITATION STYLE
Onuchukwu, I. C., Etim, E. U., Chimdike, O. G., Oguzie, B. C., Emuebie, H., Orji, K. N., … Uchendu, I. K. (2022). Review on Atherogenic Index of Plasma Lipids and Dyslipidemia. Journal of Drug Delivery and Therapeutics, 12(4-S), 214–222. https://doi.org/10.22270/jddt.v12i4-s.5477
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.